Co-Diagnostics Registers 39.6M Shares for Resale From Astor Convertible Loan
CODX is trading near its 52-week low of $0.35 (3.3% above the low).
Summary
Co-Diagnostics registered 39,594,495 shares for resale by lender J.J. Astor, the stock backing its $2.1M convertible loan. Because the float is priced at 90% of the lowest 10-day VWAP, dilution grows as the price falls, and the company gets none of the proceeds.
Key Events · Financing and Capital Events · CODX
-
39.6M Shares Registered for Astor Resale
The S-3 covers resale of 39,594,495 shares issued or issuable on conversion of the Astor notes plus 600,000 commitment shares, against 9,491,892 shares outstanding as of October 31, 2026.
-
Floating Conversion Price Compounds Dilution
Conversion is priced at the greater of 90% of the lowest 10-day VWAP and the Nasdaq minimum price ($1.09 for the Initial Note), with a floor at 20% of that minimum and six-month resets — so a falling share price mechanically increases the share count.
-
Company Receives No Resale Proceeds
All net proceeds from the resale go to the selling stockholder; Co-Diagnostics bears the registration costs, estimated at $41,453.67 including a $1,453.67 SEC fee.
-
ATM Cash Already Pledged to Lender
Under the ATM Waterfall Distribution Agreement, 100% of ATM net proceeds flow to Astor, with the first $1.0 million payable to the lender and 80% of the remainder applied to the notes.
Analysis · CODX · Industrial Applications And Services
This filing puts a hard number on dilution that the October 13 8-K only sketched. Astor can resell up to 39,594,495 shares — roughly four times the 9,491,892 shares outstanding as of October 31, 2026 — and because the conversion price floats at 90% of the lowest 10-day VWAP, a lower stock price means more shares for Astor. Against a $3.2M market cap and a going-concern warning with $3.6M of cash, that is structural downward pressure on the share price rather than a one-time event. Co-Diagnostics receives no proceeds from these sales; all ATM cash already flows to Astor under the waterfall agreement.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $0.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $0.35 to $13.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.